Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected6M Return
Four symbols is the limit; remove one to add another.
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | ALMS | JAGX | GTBP | ANVS |
|---|---|---|---|---|
| Return | ||||
| Last Price | — | — | 0.24 | — |
| Daily Change | — | — | − 3.21% | — |
| Period ReturnPast 6 Months | − 62.11% | − 97.98% | − 48.12% | — |
| Valuation | ||||
| Market Cap | $1.42 B | $2.95 M | $10.8 M | $48.0 M |
| P/E Ratio | — | — | 2.01 | — |
| Dividend Yield | — | — | — | — |
| Net MarginTrailing 12M | 6,114.6% | — | 26,209.5% | — |
| Risk | ||||
| Beta | 0.68 | — | 0.85 | — |
| 52-Week Range | 3.76 — $31.35 | — | 0.25 — $1.37 | — |
| Company | ||||
| Sector | — | — | — | — |
| Industry | Pharmaceuticals | Pharmaceuticals | Biotechnology | Biotechnology |
Company
- ALMSPharmaceuticals
- JAGXPharmaceuticals
- GTBPBiotechnology
- ANVSBiotechnology
Metrics could not be loaded for JAGX, ANVS: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 22:13
To Understand This